A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke. (BMACS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01832428|
Recruitment Status : Unknown
Verified September 2014 by Dr. Sachin Jamadar, Chaitanya Hospital, Pune.
Recruitment status was: Recruiting
First Posted : April 16, 2013
Last Update Posted : September 17, 2014
|Condition or disease||Intervention/treatment||Phase|
|Stroke,||Other: Intra thecal transplantation of Autologous Stem Cells||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke. It is Self Funded (Patients' Own Funding) Clinical Trial|
|Study Start Date :||September 2014|
|Estimated Primary Completion Date :||September 2016|
|Estimated Study Completion Date :||November 2016|
Transfer of autologous MNC intrathecally
Intra thecal transplantation of autologous stem cells 100 Millions per dose in 3 divided doses at interval of 7days.
Other: Intra thecal transplantation of Autologous Stem Cells
Intra thecal transplantation of Autologous Stem Cells
- Improvement in power of Body and facial Muscles [ Time Frame: 6 Months ]Improvement in power of Body and facial Muscles.
- Improvement in Walking Ability [ Time Frame: 6 months ]Improvement in Walking Ability in 6 month.
- Improvement In Speech and cognition [ Time Frame: 6 Months ]- Improvement In Speech and cognition ,Time period-6 month
- Improvement in Vision in both eyes [ Time Frame: 6 month ]Improvement in Vision in both eyes 6 month
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01832428
|Contact: Sachin P Jamadar, Dorthofirstname.lastname@example.org|
|Pune, Maharashtra, India, 411009|
|Contact: Sachin P Jamadar, Dortho +918888788880 email@example.com|
|Contact: Smita S Bhoyar, BAMS PGCR +9372620569 firstname.lastname@example.org|
|Principal Investigator: ANANT E BAGUL, MS|
|Principal Investigator:||ANANT E BAGUL, M.S||CHAITANYA HOSPITAL|